[Clinical experiences with an antimycotic foam preparation with added prednisolone (Nystacorton foam)].
Twenty-five infants and children with Candida infections in the perianal, genital and inguinal areas and on the skin normally covered by the napkin or diaper, confirmed by culture tests and microscopy, were treated with a new combined foam preparation containing the active substances nystatin, chlorhexidine and prednisolone. Even partially very severe lesions with multiple, satellitelike colonies on the trunk, extremities and neck were, without exception, cured within a maximum of 13 days. After disappearing of the exudative stage, intermittent treatment with a rather more greasy excipient (Excipial Cream) containing no active substance, has proved beneficial.
D000287:Administration, Topical; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002710:Chlorhexidine / Q000627:therapeutic use*; D003963:Diaper Rash / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009761:Nystatin / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use*
D004338:Drug Combinations; C048337:Nystacorton; D009761:Nystatin; D011239:Prednisolone; D002710:Chlorhexidine
Klinische Erfahrungen mit einem antimykotischen Schaumpräparat mit Zusatz von Prednisolon (Nystacorton Schaum).